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Abstract The human isopeptidase T (isoT) is a zinc-binding
deubiquitinating enzyme involved in the disassembly of free
K48-linked polyubiquitin chains into ubiquitin monomers. The
catalytic site of this enzyme is thought to be composed of
Cys335, Asp435, His786 and His795. These four residues
were site-directed mutagenized. None of the mutants were able
to cleave a peptide-linked ubiquitin dimer. Similarly, C335S,
D435N and H795N mutants had virtually no activity against
a K48-linked isopeptide ubiquitin dimer, which is an isoT-spe-
ci¢c substrate that mimics the K48-linked polyubiquitin chains.
On the other hand, the H786N mutant retained a partial activ-
ity toward the K48-linked substrate, suggesting that the His786
residue might not be part of the catalytic site. None of the
mutations signi¢cantly a¡ected the capacity of isoT to bind
ubiquitin and zinc. Thus, the catalytic site of UBPs could re-
semble that of other cysteine proteases, which contain one Cys,
one Asp and one His.
3 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Ubiquitin is a highly conserved 76 amino acid protein. The
covalent addition of polyubiquitin chains to cellular proteins
is speci¢cally recognized for selective degradation by the pro-
teasome [1]. Ubiquitination of proteins is a sequential enzy-
matic reaction involving an ubiquitin activating enzyme (E1),
an ubiquitin conjugating enzyme (E2) and an ubiquitin ligase
(E3) [2,3]. Polyubiquitin chains are attached to their substrate
through an isopeptide bond between the C-terminal carbox-
ylate of ubiquitin and the O-amino group of a speci¢c lysine
lateral chain of the substrate protein. In polyubiquitin chains,
ubiquitin molecules are also linked to one another by an iso-
peptide bond through the ubiquitin K48 residue. Nevertheless,
ubiquitination is more than a proteasomal targeting signal,
and other lysines of ubiquitin besides Lys48 are used to
form polyubiquitin chains [3].
The reversibility of ubiquitination is conferred by speci¢c
proteases called deubiquitinating enzymes which are subdi-
vided into ubiquitin C-terminal hydrolases (UCHs) and ubiq-
uitin-speci¢c processing proteases (UBPs). UCHs are not re-
lated in primary sequence to UBPs. UBPs hydrolyze
isopeptide bonds between ubiquitin and the substrate protein
or within polyubiquitin chains [3]. Human isopeptidase T
(isoT) is an UBP capable of binding ubiquitin that speci¢cally
disassembles free polyubiquitin chains linked through isopep-
tide bonds involving the K48 of ubiquitin into ubiquitin
monomers [4,5]. The isoT is the only UBP known to require
zinc binding to be active [6].
The UBPs are characterized by the presence of three con-
served domains surrounding, respectively, one cysteine (Cys
box), one aspartic acid (Asp box) and two histidine residues
(His box) [7^10]. These residues are postulated to form the
catalytic site of UBPs by analogy with other proteases. This
idea has been reinforced, both in vivo and in vitro, by muta-
genesis experiments showing that these residues are needed for
deubiquitinating activity in UBPs toward a variety of generic
substrates [5,11^19]. The inhibition of UBPs by covalent in-
hibitors such as ubiquitin aldehyde or ubiquitin vinyl sulfone
strongly suggests the presence of a Cys residue in the active
site, as found in UCHs [20^23]. Nevertheless, there is at
present no direct evidence that these residues are e¡ectively
part of the catalytic site.
In this study, we mutagenized for the ¢rst time the four
highly conserved residues of the putative catalytic site of the
human isoT. Previous studies were done on other members of
the UBP family using generic substrates that may have lacked
high a⁄nity for the UBP analyzed. We de¢ned the importance
of these residues in the isoT activity toward its speci¢c sub-
strate, and in the capacity of isoT to bind zinc and ubiquitin.
2. Materials and methods
2.1. IsoT site-directed mutagenesis
The C335S and D435N mutations were produced by reverse PCR
(by the QuickChange1 method, Stratagene, La Jolla, CA, USA) us-
ing the complete pMPM-isoT-S wt (wild-type) plasmid [6] as a tem-
plate. XL1-Blue bacteria were then electroporated using 1 Wl of the
DpnI-treated PCR reaction. The entire isoT ORFs were veri¢ed by
sequencing.
The H786N and H795N mutations were produced by a two-step
PCR-based approach [5] from the pMPM-isoT-S wt plasmid as a
template. The ¢nal product was cloned in the pMPM-isoT-S wt plas-
mid as a Eco47III/FseI fragment. The sequences encompassing the
mutagenized Eco47III/FseI fragments were veri¢ed by sequencing.
2.2. IsoT expression and puri¢cation
Wt and mutated isoT were expressed in the MC1061 Escherichia
coli strain, and cells were lysed as previously described [6]. IsoT was
puri¢ed on an ubiquitin^Sepharose column. The loaded ubiquitin^
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Sepharose column was washed with bu¡er A (50 mM Tris^HCl, pH
7.2, 0.2 mM EDTA, 5% glycerol, 1 mM DTT), bu¡er B (bu¡er A+0.5
M KCl), and once again bu¡er A. IsoT was eluted in bu¡er C (bu¡er
A+3 M KSCN). Finally, isoT was dialyzed against 50 mM Tris^HCl,
pH 7.2, 1 mM DTT and kept at 320‡C until use.
2.3. Substrates synthesis
IsoT activity was monitored using both linear and branched ubiq-
uitin dimers as substrates.
The linear ubiquitin dimer was expressed from pMPM250-HUb2 in
the Bl21(DE3) E. coli strain as a 6His-tagged protein [6], and puri¢ed
on a Ni-NTA column (Qiagen, Hilden, Germany). The linear dimer is
linked head-to-tail through a peptide bond.
The branched ubiquitin dimer was synthesized using human E1 and
E225K enzymes, and puri¢ed as previously described [6] but with the
following modi¢cations. Both human E1 and E225K were expressed as
recombinant proteins in the MC1061 E. coli strain harboring the
pMPM201-E1 (a kind gift from L. Falquet) or the pMPM201-E225K
[6] plasmids. Cells were lysed as described for isoT except that 2 mM
ATP was added to the crude extract, and human E1 was loaded onto
an ubiquitin^Sepharose a⁄nity chromatography equilibrated in bu¡er
A (50 mM Tris^HCl, pH 7.2, 5% glycerol, 5 mM MgCl2, 2 mM ATP).
After washing with bu¡er B (50 mM Tris^HCl, pH 7.2, 1 M KCl, 5%
glycerol) and bu¡er C (50 mM Tris^HCl, pH 7.2, 5% glycerol), E1
enzyme was eluted with bu¡er D (50 mM Tris^HCl, pH 7.2, 0.5 mM
MgCl2, 2 mM AMP, 40 WM Na2PPi, 5% glycerol), and further con-
centrated onto a DE52 column eluted with bu¡er A+0.5 M KCl with-
out DTT. The E225K catalyzes the synthesis of K48-linked ubiquitin
dimers, in which one monomer is linked to the internal K48 of the
other through an isopeptide bond [24,25].
2.4. IsoT activity assay
The enzymatic reaction was performed in a 15 Wl total volume.
Indicated quantities of isoT were pre-incubated for 15 min at 22‡C
in 50 mM Tris^HCl, pH 7.2, 1 mM DTT. The linear and branched
substrates were added to the reaction at a ¢nal concentration of 5.5
WM (1.5 Wg) and 5.8 WM (1.5 Wg), respectively, and then further in-
cubated at 37‡C for the indicated times. The reaction was stopped by
adding 3Wl of six-fold concentrated loading bu¡er and analyzed on a
Tris^tricine gel by Coomassie staining.
2.5. Ubiquitin-binding assay
The binding of wt and mutated isoT to ubiquitin was assessed using
an FPLC column where ubiquitin (Sigma, St. Louis, MO, USA) was
covalently coupled to a HiTrap NHS-activated column (Amersham
Biosciences, Buckinghamshire, UK). The column was equilibrated in
bu¡er A (10 mM NaH2PO4/Na2HPO4, pH 7, 2 mM L-mercaptoeth-
anol) and submitted to two consecutive gradients in bu¡er A: a 0^3
M KCl linear gradient followed by a 0^8 M urea linear gradient. The
gradients were performed using a FPLC station (Amersham Bioscien-
ces). The urea concentration needed to elute isoT was de¢ned as the
timepoint of maximum absorbance at 278 nm of the elution pro¢le.
3. Results
3.1. Relative importance of C335, D435, H786 and H795
residues in the enzymatic reaction
The activity of the isoT catalytic site mutants was measured
using two types of substrates: linear and branched ubiquitin
dimers (see Section 2). IsoT is known to cleave these two
substrates [26] but in vitro, it has a preference for the
branched one [4,26]. On one hand, the linear dimer is related
to arti¢cial ubiquitin fusion proteins, such as Ub^L-galactosi-
dase, which are classically used to analyze the deubiquitinat-
ing activity of UBPs. It is also related to naturally occurring
precursors where ubiquitin is fused with ribosomal proteins or
to another ubiquitin molecule in a ubiquitin polymer. On the
other hand, the branched dimer mimics the speci¢c in vivo
substrate of the isoT enzyme, the K48-linked polyubiquitin
chains [5]. For this reason, the branched dimer might enhance
the sensitivity of the assay.
In a ¢rst approach the activities of the C335S (Cys box),
D435N (Asp box), H786N and H795N (His box) mutants
were tested according to the standard conditions used in the
laboratory in which wt isoT almost completely cleaves both
substrates (Fig. 1A,B). As expected none of the mutants of the
four conserved residues of the putative catalytic site of isoT
had detectable activity against the linear dimer (Fig. 1B). The
C335S, D435N, and H795N mutants also showed no activity
against the branched dimer (Fig. 1A). The H786N mutant was
capable of cleaving the branched dimer, although to a lower
extent compared to wt isoT (Fig. 1A).
To further study the enzymatic activity of H786N isoT, a
time-course was performed at an enzymatic concentration of
0.1 WM (Fig. 2). While wt isoT almost completely cleaved the
branched dimer in 5 min (Fig. 2A), the H786N mutant
cleaved more slowly since after 15 min of reaction less than
Fig. 1. IsoT activity tested on linear and branched ubiquitin dimers.
Reaction products were analyzed on a Tris^tricine gel by Coomassie
staining. The reaction was performed as previously described [6],
under conditions that allowed almost complete cleavage of branched
(A) and linear (B) ubiquitin dimers (i.e. a 15 Wl reaction containing
0.1 WM of isoT, 1.5 Wg of substrate and performed at 37‡C during
5 min). , branched dimer; , linear dimer. Ub, ubiquitin;
HUb, 6His-ubiquitin.
Fig. 2. Time-course reaction comparing the activity of wt and
H786N isoT toward the branched ubiquitin dimer. Reaction prod-
ucts were analyzed on a Tris^tricine gel by Coomassie staining. The
reaction was performed at 37‡C in a volume of 15 Wl containing 0.1
WM of wt (A) or H786N (B) isoT, 1.5 Wg of branched substrate, for
the indicated times. Ub, ubiquitin.
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one half of the branched ubiquitin dimer was cleaved (Fig.
2B).
A more detailed analysis of the four mutants was carried
out on both ubiquitin dimers (Fig. 3) to reveal if any activity
could be detected with the C335S, D435N and H795N mu-
tants. This was done by increasing the enzyme concentration
until enzymatic activity could be observed. The enzymatic
activity of the wt isoT toward branched dimer could be visu-
alized in a 5 min reaction at an enzyme concentration of 0.02
WM. All the mutants were capable of cleaving branched dimer,
but only at much higher enzyme concentrations. The H786N
mutant needed 0.1 WM for the same level of reaction. D435N
and H795N mutants required a reaction time of 1 h and a
concentration of 0.5 WM to give a perceptible cleavage of the
branched substrate, whereas the C335S mutant needed a re-
action time of 1 h at a 1 WM concentration. According to the
enzymatic reactions presented here, the C335S mutation was
the most drastic, followed by the D435N and H795N muta-
tions which a¡ect the deubiquitinating activity in a similar
manner, and ¢nally the H786N mutation which retained a
partial but signi¢cant activity (C335SsD435NWH795N
s sH786N). However we cannot exclude that other amino
acid substitutions could a¡ect the isoT activity di¡erently. For
example, a C335A mutation should remove any possible acti-
Fig. 3. Detailed analysis of the isoT mutants activity using a broader range of reaction conditions. Reaction products were analyzed on a Tris^
tricine gel by Coomassie staining. The reaction was performed at 37‡C in a volume of 15 Wl containing 1.5 Wg of branched substrate, the indi-
cated concentrations of wt (A), C335S (B), D435N (C), H786N (D) and H795N (E) isoT, for the indicated times. The enzyme concentrations
used to detect the enzymatic activity varied according to the mutant analyzed. Ub, ubiquitin; HUb, 6His-ubiquitin.
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vation of the nucleophile. Moreover the pH optimum for
enzymatic activity is perhaps altered in the C335S mutant
compared to the wt enzyme. None of the mutants were capa-
ble of cleaving linear dimers even after 1 h reaction with 1 WM
of enzyme; this con¢rms the higher activity of isoT for
branched compared to linear dimer.
3.2. Zinc and ubiquitin binding are independent of the conserved
catalytic residues
The isoT binds both zinc and ubiquitin. Zinc is required for
the isoT activity [6], but its exact role in the enzymatic reac-
tion is unknown. Since Cys, His and Asp residues are poten-
tial zinc ligands, the residues of the putative catalytic site
could be involved in zinc binding, although these residues
were never described as having the characteristic features of
a zinc-binding site. To test this possibility, isoT zinc content
was measured by atomic absorption spectrophotometry. Wt
isoT contained one zinc as did the C335S, D435N, H786N
and H795N mutants (Table 1).
To further study the e¡ect of mutations in the putative
catalytic site, an ubiquitin-binding assay was performed to
determine if the loss of activity could not be a consequence
of a defect in ubiquitin binding. The binding of isoT to ubiq-
uitin was measured using a ubiquitin^Sepharose column sub-
mitted to a tandem KCl and urea linear gradients. None of
the proteins were eluted in the KCl gradient, whereas the wt
isoT and the C335S, D435N, H786N and H795N mutants
were all eluted at approximately 5.8 M urea (Table 2), show-
ing that the ubiquitin^isoT interaction was only disrupted at
high urea concentrations, probably as a result of isoT dena-
turation.
Thus, the mutations of the conserved residues exclusively
a¡ect the catalytic activity of isoT but apparently not zinc nor
ubiquitin binding.
4. Discussion
This study describes an in vitro analysis of the putative
catalytic residues of an UBP using a speci¢c substrate mim-
icking the natural substrate, instead of a generic substrate that
lacked speci¢city for the UBP analyzed. This approach al-
lowed us to study more precisely the importance of each res-
idue in the reaction and to get more insight into the enzymatic
mechanism of UBPs.
The only previous in vitro study of the four highly con-
served amino acids of the UBPs was on the DUB-2A enzyme
using a generic Ub^L-galactosidase chimeric substrate [13]. In
this study, the four residues appeared to be critical for the
deubiquitinating activity. Several other studies showed that
the conserved cysteine and histidines are necessary for the
enzymatic activity of various UBPs both in vivo and in vitro
[5,11,12,14^19].
Since isoT mutants bind zinc and ubiquitin as e⁄ciently as
the wt isoT, it appears that defects in the catalytic site of the
enzyme are probably at the origin of the loss of or decrease in
activity observed in the isoT mutants. At the highest isoT
concentration used, C335S, D435N, and H795N mutants are
completely inactive toward linear ubiquitin dimers, and very
slightly active toward branched ubiquitin dimers. This pro-
vides further evidence that these residues are necessary for
enzymatic activity and constitute part of the catalytic site.
Although inactive on the linear ubiquitin dimer, the H786N
Table 1
Zinc binding of isoT
IsoT Zinc/isoT (mol/mol)
Wt 1.04T 0.05
C335S 1.0T 0.03
D435N 1.03T 0.02
H786N 1.04T 0.06
H795N 1.09T 0.06
IsoT zinc content was assessed by atomic absorption spectropho-
tometry (spectrophotometer Perkin Elmer 238O) as previously de-
scribed [6], from recombinant isoT puri¢ed from E. coli. Results are
expressed in mol/mol as meanTS.D. of six separate experiments.
Table 2
IsoT binding to ubiquitin
IsoT IsoT elution [urea] M
Wt 5.81T 0.08
C335S 5.67T 0.01
D435N 5.82T 0.03
H786N 5.60T 0.01
H795N 5.93T 0.03
IsoT a⁄nity to ubiquitin was assessed by an urea gradient applied
onto a ubiquitin^Sepharose column. Results are expressed in molar
(M) as meanTS.D. of three separate experiments.
Fig. 4. Schematic representation of the conserved domains in human isoT. The catalytic site includes three domains named Cys, Asp and His
boxes containing, respectively, the C335, D435, H786 and H795 residues in isoT. In human UCH-L3 and yeast Ulp1 the catalytic triad is com-
posed respectively, of C95, H169, and D184 [32], and of C580, D531, and H514 [31]. Q89 in UCH-L3 [32], Q574 in Ulp1 [31] and potentially
Q342 in isoT form the oxyanion hole. The UBA1, UBA2 [34] and the ZnF-UBP [37] domains constitute the putative ubiquitin-binding do-
mains. The Cys and His boxes are de¢ned according to the Pfam database (domains PF00442 and PF00443, respectively); the Asp box is de-
¢ned according to [8].
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mutant retains a signi¢cant capacity to cleave the branched
ubiquitin dimer, a substrate that more closely mimics the spe-
ci¢c substrate of isoT. This partial loss of the deubiquitinating
activity is also observed in another UBP, the mouse Unp, in
which the corresponding His was replaced by an Ala [27]. On
the contrary, when replaced by an Arg, this His appeared to
be critical for the in vivo function of the Fat Facets UBP in
Drosophila [11]. However, it is unknown if the catalytic activ-
ity per se of this Fat Facets mutant is a¡ected. Besides isoT
[4,5], speci¢c ubiquitinated substrates of Fat Facets [28] and
USP7 [29] are also identi¢ed. So, it would be interesting to see
if these UBPs have the same in vitro properties.
The capacity of the H786N mutant to cleave the branched
ubiquitin dimers raises the possibility that the His786 residue
is not part of the catalytic site even though this residue is
conserved in all the known UBPs. Instead, it could be in-
volved in the correct positioning of the substrate or in the
structure of the catalytic site. Thus, the catalytic site of
UBPs could be formed by one Cys, one Asp and only one
His; it could resemble the catalytic site of the UCH and Ulp
protease families that are involved, respectively, in ubiquitin
and SUMO (an ubiquitin-like protein) recycling and/or mat-
uration [23,30,31]. In these cysteine proteases, the nucleophilic
cysteine is coordinated by a histidine general base, which is in
turn stabilized by an aspartic acid. In isoT, the catalytic triad
would be composed of Cys335, Asp435 and His795. Since, in
Ulps and UCHs, the catalytic Asp residue is close to the His
residue in the primary structure, a conserved Asp residue in
the His box (Asp811) could be part of the catalytic site instead
of the Asp435 (Fig. 4). Three conserved Asn residues (Asn330,
Asn333 and Asn338) contained in the Cys box could also be
potential catalytic residues in place of the Asp435 residue. In
addition to the catalytic triad, UCH and Ulp enzymes contain
a Gln as an oxyanion hole ([32] and Fig. 4). In UBPs a Gln is
fully conserved in the Cys box (Q342 in isoT) and could
potentially play this role. Two other Gln are present in the
Asp box (Q433 and Q434 in isoT), but they are less conserved.
An extensive mutational analysis of these residues could re-
veal any role they might play in enzymatic activity.
The observation that none of the mutants of the isoT pu-
tative catalytic site are a¡ected in their capacity to bind ubiq-
uitin or zinc suggests that other parts of the isoT protein are
involved in these functions. Two ubiquitin-binding sites were
described in isoT [4,33], whereas isoT contains two copies of
an UBA domain capable of binding ubiquitin [34,35]. It is not
known if these UBA domains constitute one or two ubiquitin-
binding sites. Besides the UBA domains, the ZnF-UBP/
DAUP domain (PF02148 in Pfam database, [36]), which is
involved in the binding of a histone deacetylase to ubiquitin
[37], could also constitute one of the two binding sites. This
ZnF-UBP domain could represent the veritable site of zinc
binding since it is depicted as a putative zinc-binding site. In
contrast, although being potential zinc ligands, the putative
catalytic residues are not involved in zinc binding. These res-
idues are conserved amongst all UBPs even though some
UBPs are not zinc-binding proteins (T. Lacombe, unpublished
data).
Although further investigations are necessary to fully
understand the role of each catalytic residue in the enzymatic
reaction, such as kinetic and a⁄nity measurements, or crys-
tallization experiments, this study allowed us to go another
step forward in the understanding of the UBPs functioning.
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